Klingman & Associates’s Lam Research LRCX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.18M Buy
3,596
+444
+14% +$139K 0.05% 132
2026
Q2
$1.37M Buy
3,152
+253
+9% +$76.8K 0.06% 116
2026
Q1
$619K Buy
2,899
+349
+14% +$78K 0.03% 175
2025
Q4
$437K Buy
2,550
+183
+8% +$28.5K 0.02% 207
2025
Q3
$317K Buy
2,367
+240
+11% +$25.4K 0.02% 244
2025
Q2
$207K Buy
+2,127
New +$169K 0.01% 298

Other funds holding LRCX

Klingman & Associates's LRCX Position: Q3 2026 in Review

Klingman & Associates increased its Lam Research (LRCX) stake by 14% in Q3 2026, buying an estimated $139K and bringing the position to 3,596 shares worth $1.18M. The position accounts for 0.05% of the portfolio, ranked #132.

Klingman & Associates first reported a position in LRCX in Q2 2025 and has held it in 6 quarters since. The position peaked at $1.37M in Q2 2026. 1,983 funds tracked by Wall St. Rank hold LRCX as of Q3 2026.

  • Klingman & Associates held 3,596 shares of Lam Research worth $1.18M as of Q3 2026.
  • Klingman & Associates bought 444 Lam Research shares in Q3 2026, an estimated $139K.
  • Lam Research made up 0.05% of Klingman & Associates's portfolio in Q3 2026, its #132 holding.
  • Klingman & Associates first reported a position in Lam Research in Q2 2025 and has held it in 6 quarters since.
  • Klingman & Associates's Lam Research position peaked at $1.37M in Q2 2026.
  • 1,983 funds tracked by Wall St. Rank held Lam Research as of Q3 2026.

Based on Klingman & Associates's 13F filing for Q3 2026, filed 20 Oct 2026.